Standard lung function tests clear millions of young vapers as healthy — but that reassurance may be masking real physiological damage. A new controlled study published in Chest reveals that the harm from chronic e-cigarette use only becomes visible when the cardiopulmonary system is pushed under exercise stress, raising urgent questions about long-term consequences in a generation that has normalized vaping.
Using cardiopulmonary exercise testing, researchers compared 20 chronic e-cigarette users (mean age 23, no tobacco history) against 20 carefully matched non-using controls. Despite both groups recording normal resting pulmonary function, the vaping cohort demonstrated measurably lower peak oxygen uptake (VO₂peak, p=.017), indicating reduced aerobic capacity. They also showed elevated ventilatory inefficiency — a higher minute ventilation to CO₂ output nadir ratio (p=.037) — meaning they had to breathe more for every unit of CO₂ eliminated, a hallmark of disordered respiratory control or impaired gas exchange. A secondary analysis examining pulmonary diffusing capacity for carbon monoxide (DLCO) from seated to supine posture found blunted recruitment in vapers, suggesting early-stage microvascular or alveolar dysfunction that rest-based screening fails to capture.
This study matters for several reasons beyond its modest sample size of 40 participants. First, it methodologically demonstrates why resting spirometry is an inadequate sentinel for vaping-related harm — exercise-provoked testing is far more sensitive. Second, the blunted DLCO recruitment finding fits a plausible biological mechanism: e-cigarette aerosols deliver reactive aldehydes and ultrafine particles known to cause oxidative stress in pulmonary endothelium, potentially compromising alveolar-capillary reserve. Third, these participants were young adults in their early twenties, the very demographic with the greatest physiological reserve, yet impairment was already detectable. This is an early-signal study — small, cross-sectional, and unable to establish causation or dose-response — but its findings align with emerging preclinical and epidemiological literature pointing to vaping as a genuine cardiopulmonary stressor, not a benign tobacco alternative. Longitudinal studies tracking DLCO and VO₂peak trajectories in vapers are now warranted.